FIELD: medicine, psychopharmacology.
SUBSTANCE: invention proposes using bioactive metabolite of hepirone for preparing a medicinal agent designated for reducing the depression severity or anxiety or their symptoms in mammals. Agent is chosen from the group comprising 3-(OH)-hepirone, 3,5-dihydroxyhepirone, 5-(OH)-hepirone or its pharmaceutically acceptable salt or hydrate. Invention expands the assortment of medicinal agents used in psychiatry.
EFFECT: valuable medicinal properties of metabolites.
4 cl, 2 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS COMPRISING INHIBITORS OF DOPAMINE RE-UPTAKE AND METHODS FOR THEIR USING | 1999 |
|
RU2238084C2 |
| COMPOSITIONS CONTAINING MONOAMINE REUPTAKE INHIBITOR AND METHODS OF THEIR APPLICATION | 2004 |
|
RU2358719C2 |
| METHOD OF TREATING MAJOR DEPRESSION IN HUMAN | 2007 |
|
RU2445973C2 |
| CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR PHRENOPATHY TREATMENT | 2003 |
|
RU2356554C2 |
| ORGANIC COMPOUNDS | 2017 |
|
RU2733975C2 |
| CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR TREATING PHRENOPATHIES | 2008 |
|
RU2389490C2 |
| METHOD FOR SUPPRESSION OF FEAR SENSATION | 2000 |
|
RU2254132C2 |
| NEW METHODS | 2014 |
|
RU2682658C1 |
| DERIVATIVES OF CARBOSTYRIL AND STABILISERS OF MOOD FOR TREATMENT OF DISORDERS OF MOOD | 2004 |
|
RU2359675C2 |
| USE OF TESTOSTERONE ANALOGUE AND 5-HT1A AGONIST FOR SEXUAL DYSFUNCTION TREATMENT | 2012 |
|
RU2646447C2 |
